Caforio ALP, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Felix SB, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2013;34(33):2636–48.

Article  PubMed  Google Scholar 

Management of Acute Myocarditis and Chronic Inflammatory Cardiomyopathy | Circulation: Heart Failure [Internet]. [cited 2024 Aug 31]. Available from: https://www.ahajournals.org/doi/https://doi.org/10.1161/CIRCHEARTFAILURE.120.007405

Merlo M, Ammirati E, Gentile P, Artico J, Cannatà A, Finocchiaro G, et al. Persistent left ventricular dysfunction after acute lymphocytic myocarditis: Frequency and predictors. PLoS ONE. 2019;14(3):e0214616.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Corrado D, PerazzoloMarra M, Zorzi A, Beffagna G, Cipriani A, Lazzari MD, et al. Diagnosis of arrhythmogenic cardiomyopathy: The Padua criteria. Int J Cardiol. 2020;15(319):106–14.

Article  Google Scholar 

Gilotra NA, Bhonsale A, James CA, te Riele ASJ, Murray B, Tichnell C, et al. Heart Failure Is Common and Under-Recognized in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia. Circ Heart Fail. 2017;10(9):e003819.

Article  PubMed  Google Scholar 

Sen-Chowdhry S, Syrris P, Prasad SK, Hughes SE, Merrifield R, Ward D, et al. Left-dominant arrhythmogenic cardiomyopathy: an under-recognized clinical entity. J Am Coll Cardiol. 2008;52(25):2175–87.

Article  PubMed  Google Scholar 

Bariani R, Cipriani A, Rizzo S, Celeghin R, Bueno Marinas M, Giorgi B, et al. ‘Hot phase’ clinical presentation in arrhythmogenic cardiomyopathy. Eur Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol. 2021;23(6):907–17.

Google Scholar 

Wang W, Murray B, Tichnell C, Gilotra NA, Zimmerman SL, Gasperetti A, et al. Clinical characteristics and risk stratification of desmoplakin cardiomyopathy. EP Eur. 2022;24(2):268–77.

CAS  Google Scholar 

Lota AS, Hazebroek MR, Theotokis P, Wassall R, Salmi S, Halliday BP, et al. Genetic Architecture of Acute Myocarditis and the Overlap With Inherited Cardiomyopathy. Circulation. 2022;146(15):1123–34.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Artico J, Merlo M, Delcaro G, Cannat à A, Gentile P, De AG, et al. Lymphocytic Myocarditis. J Am Coll Cardiol. 2020;75(24):3098–100.

Article  PubMed  Google Scholar 

Mavrogeni S, Papavasiliou A, Spargias K, Constandoulakis P, Papadopoulos G, Karanasios E, et al. Myocardial inflammation in duchenne muscular dystrophy as a precipitating factor for heart failure: a prospective study. BMC Neurol. 2010;10(1):33.

Article  PubMed  PubMed Central  Google Scholar 

Tiron C, Campuzano O, Fernández-Falgueras A, Alcalde M, Loma-Osorio P, Zamora E, et al. Prevalence of pathogenic variants in cardiomyopathy-associated genes in myocarditis. Circ Genomic Precis Med. 2022;15(3):e003408.

Article  CAS  Google Scholar 

Belkaya S, Kontorovich AR, Byun M, Mulero-Navarro S, Bajolle F, Cobat A, et al. Autosomal recessive cardiomyopathy presenting as acute myocarditis. J Am Coll Cardiol. 2017;69(13):1653–65.

Article  PubMed  PubMed Central  Google Scholar 

Scheel PJ, Murray B, Tichnell C, James CA, Tandri H, Calkins H, et al. arrhythmogenic right ventricular cardiomyopathy presenting as clinical myocarditis in women. Am J Cardiol. 2021;15(145):128–34.

Article  Google Scholar 

Smith ED, Lakdawala NK, Papoutsidakis N, Aubert G, Mazzanti A, McCanta AC, et al. Desmoplakin cardiomyopathy, a fibrotic and inflammatory form of cardiomyopathy distinct from typical dilated or arrhythmogenic right ventricular cardiomyopathy. Circulation. 2020;141(23):1872–84.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ammirati E, Raimondi F, Piriou N, SardoInfirri L, Mohiddin SA, Mazzanti A, et al. Acute myocarditis associated with desmosomal gene variants. JACC Heart Fail. 2022;10(10):714–27.

Article  CAS  PubMed  Google Scholar 

Bariani R, Rigato I, Cipriani A, Bueno Marinas M, Celeghin R, Basso C, et al. Myocarditis-like episodes in patients with arrhythmogenic cardiomyopathy: a systematic review on the so-called hot-phase of the disease. Biomolecules. 2022;12(9):1324.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Calore M, Lorenzon A, De Bortoli M, Poloni G, Rampazzo A. Arrhythmogenic cardiomyopathy: a disease of intercalated discs. Cell Tissue Res. 2015;360(3):491–500.

Article  CAS  PubMed  Google Scholar 

Gigli M, Stolfo D, Graw SL, Merlo M, Gregorio C, Nee Chen S, et al. Phenotypic expression, natural history, and risk stratification of cardiomyopathy caused by filamin C truncating variants. Circulation. 2021;144(20):1600–11.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vrettos A, Demetriades P, Ortiz M, Domínguez F, García-Pavía P, Suárez-Mier MP, et al. Pathogenic truncating filamin C mutations presenting as acute myocarditis: a case series with insights from cardiac magnetic resonance and histological analysis. Eur Heart J - Case Rep. 2024;8(3):ytae111.

Article  PubMed  PubMed Central  Google Scholar 

Vafiadaki E, Glijnis PC, Doevendans PA, Kranias EG, Sanoudou D. Phospholamban R14del disease: The past, the present and the future. Front Cardiovasc Med [Internet]. 2023 Apr 18 [cited 2024 Aug 31];10. Available from: https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2023.1162205/full

Campuzano O, Alcalde M, Iglesias A, Barahona-Dussault C, Sarquella-Brugada G, Benito B, et al. Arrhythmogenic right ventricular cardiomyopathy: severe structural alterations are associated with inflammation. J Clin Pathol. 2012;65(12):1077–83.

Article  PubMed  Google Scholar 

Lubos N, van der Gaag S, Gerçek M, Kant S, Leube RE, Krusche CA. Inflammation shapes pathogenesis of murine arrhythmogenic cardiomyopathy. Basic Res Cardiol. 2020;115(4):42.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Valente M, Calabrese F, Thiene G, Angelini A, Basso C, Nava A, et al. In vivo evidence of apoptosis in arrhythmogenic right ventricular cardiomyopathy. Am J Pathol. 1998;152(2):479–84.

CAS  PubMed  PubMed Central  Google Scholar 

Meraviglia V, Alcalde M, Campuzano O, Bellin M. Inflammation in the Pathogenesis of Arrhythmogenic Cardiomyopathy: Secondary Event or Active Driver? Front Cardiovasc Med [Internet]. 2021 Dec 20 [cited 2024 Aug 31];8. Available from: https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2021.784715/full

Kontorovich AR, Patel N, Moscati A, Richter F, Peter I, Purevjav E, et al. Myopathic cardiac genotypes increase risk for myocarditis. JACC Basic Transl Sci. 2021;6(7):584–92.

Article  PubMed  PubMed Central  Google Scholar 

Chelko SP, Asimaki A, Lowenthal J, Bueno-Beti C, Bedja D, Scalco A, et al. Therapeutic modulation of the immune response in arrhythmogenic cardiomyopathy. Circulation. 2019;140(18):1491–505.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Corrado D, Basso C, Thiene G, McKenna WJ, Davies MJ, Fontaliran F, et al. Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study. J Am Coll Cardiol. 1997;30(6):1512–20.

Article  CAS  PubMed  Google Scholar 

Basso C, Thiene G, Corrado D, Angelini A, Nava A, Valente M. Arrhythmogenic right ventricular cardiomyopathy. Circulation. 1996;94(5):983–91.

Article  CAS  PubMed  Google Scholar 

Asatryan B, Asimaki A, Landstrom AP, Khanji MY, Odening KE, Cooper LT, et al. Inflammation and immune response in arrhythmogenic cardiomyopathy: state-of-the-art review. Circulation. 2021;144(20):1646–55.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mavroidis M, Davos CH, Psarras S, Varela AC, Athanasiadis N, Katsimpoulas M, et al. Complement system modulation as a target for treatment of arrhythmogenic cardiomyopathy. Basic Res Cardiol. 2015;110(3):27.

Article  PubMed  Google Scholar 

Chen L, Yi M, Song J, Hu S. Complement system is highly activated and potentially acts as a biomarker for patients with arvc. J Am Coll Cardiol. 2018;71(11_Supplement):A745–A745.

Article  Google Scholar 

Chelko SP, Penna VR, Engel M, Shiel EA, Centner AM, Farra W, et al. NFĸB signaling drives myocardial injury via CCR2+ macrophages in a preclinical model of arrhythmogenic cardiomyopathy. J Clin Invest [Internet]. 2024 Jul 5 [cited 2024 Aug 31];134(10). Available from: https://www.jci.org/articles/view/172014

Hawthorne RN, Blazeski A, Lowenthal J, Kannan S, Teuben R, DiSilvestre D, et al. Altered electrical, biomolecular, and immunologic phenotypes in a novel patient-derived stem cell model of desmoglein-2 Mutant ARVC. J Clin Med. 2021;10(14):3061.

Article